#Global Assisted Reproductive Technology Market

[janetushar1]

Assisted Reproductive Technology Market to Hit $40.9 Billion by 2032

The global Assisted Reproductive Technology Market was valued at USD 25.1 Billion in 2024 and it is estimated to garner USD 40.9 Billion by 2032 with a registered CAGR of 6.3% during the forecast period 2024 to 2032.

Global Assisted Reproductive Technology Market Research Report 2024, Growth Rate, Market Segmentation, Assisted Reproductive Technology Market. It affords qualitative and quantitative insights in phrases of market size, destiny trends, and nearby outlook Assisted Reproductive Technology Market. Contemporary possibilities projected to influence the destiny capability of the market are analyzed in the report. Additionally, the document affords special insights into the opposition in particular industries and diverse businesses. This document in addition examines and evaluates the contemporary outlook for the ever-evolving commercial enterprise area and the prevailing and future outcomes of the market.

Get Sample Copy of Report @ https://www.vantagemarketresearch.com/assisted-reproductive-technology-market-2403/request-sample

** Note: You Must Use A Corporate Email Address OR Business Details.

The Major Players Profiled in the Market Report are:-

Thermo Fisher Scientific Inc. (U.S.), Oxford Gene Technology IP Ltd. (UK), Genea Biomedx (Australia), The Cooper Companies Inc. (U.S.), Inception Sciences Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Vitrolife AB (Sweden)

Assisted Reproductive Technology Market 2024 covers powerful research on global industry size, share, and growth which will allow clients to view possible requirements and forecasts. Opportunities and drivers are assembled after in-depth research by the expertise of the construction robot market. The Assisted Reproductive Technology Market report provides an analysis of future development strategies, key players, competitive potential, and key challenges in the industry.

Global Assisted Reproductive Technology Market Report 2024 reveals all critical factors related to diverse boom factors inclusive of contemporary trends and traits withinside the worldwide enterprise. It affords a complete review of the top manufacturers, present-day enterprise status, boom sectors, and commercial enterprise improvement plans for the destiny scope.

The Assisted Reproductive Technology Market document objectives to offer nearby improvement to the market using elements inclusive of income revenue, destiny market boom rate. It gives special observation and analysis of key aspects with quite a few studies strategies consisting of frenzy and pestle evaluation, highlighting present-day market conditions. to be. Additionally, the document affords insightful records approximately the destiny techniques and opportunities of worldwide players.

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/assisted-reproductive-technology-market-2403/0

Global Assisted Reproductive Technology Market, By Region

1) North America- (United States, Canada, Mexico, Cuba, Guatemala, Panama, Barbados, and many others)

2) Europe- (Germany, France, UK, Italy, Russia, Spain, Netherlands, Switzerland, Belgium, and many others)

3) the Asia Pacific- (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Vietnam, and many others)

4) the Middle East & Africa- (Turkey, Saudi Arabia, United Arab Emirates, South Africa, Israel, Egypt, Nigeria, and many others)

5) Latin America- (Brazil, Argentina, Colombia, Chile, Peru, and many others)

This Assisted Reproductive Technology Market Research/analysis Report Contains Answers to your following Questions

What trends, challenges, and barriers will impact the development and sizing of the global market?

What is the Assisted Reproductive Technology Market growth accelerator during the forecast period?

SWOT Analysis of key players along with its profile and Porter’s five forces analysis to supplement the same.

How much is the Assisted Reproductive Technology Market industry worth in 2019? and estimated size by 2024?

How large is the Assisted Reproductive Technology Market? How long will it keep growing and at what rate?

Which section or location will force the market and why?

What is the important thing current tendencies witnessed in the Assisted Reproductive Technology Market?

Who are the top players in the market?

What and How many patents are filed by the leading players?

What is our Offering for a bright industry future?

The Research Objectives of this Report are to:-

Company, key regions/countries, merchandise and applications, historical records from 2018 to 2022, and global Assisted Reproductive Technology Market till 2032. Study and analyze the market length (cost and volume).

To recognize the structure of Assisted Reproductive Technology Market via way of means of figuring out its numerous subsegments.

Assisted Reproductive Technology Market on the subject of the primary regions (with every essential country). Predict the cost and length of submarkets.

To examine the Assisted Reproductive Technology Markets with appreciation to person boom trends, destiny prospects, and their contribution to the general market.

To examine aggressive trends consisting of expansions, contracts, new product launches, and acquisitions withinside the market.

Strategic profiling of key gamers and complete evaluation of growth strategies.

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/assisted-reproductive-technology-market-2403

Reasons to Buy Market Report

The market record presents a qualitative and quantitative analysis of the market based on segmentation that includes each economic and non-economic element.

Assisted Reproductive Technology Market through the region. The market evaluation highlights the consumption of products/services in areas and well-known shows elements influencing the market in every region.

Assisted Reproductive Technology Market. It consists of an in-depth analysis of the market from specific views via Market Porter's Five Forces Analysis and provides insights into the market via the Value Chain.

The Assisted Reproductive Technology Market file provides an outline of market fee (USD) information for every segment and sub-segment.

It consists of an in-depth analysis of the market from distinct views via a 5 forces analysis of the Assisted Reproductive Technology Market and offers insights into the market through the fee chain.

Check Out More Reports

Global Pet Insurance Market :  Report Forecast by 2032

Global Electric Powertrain Market: Report Forecast by 2032

Global AI in Video Surveillance Camera Market: Report Forecast by 2032

Global Auto Repair Software Market: Report Forecast by 2032

Global Electronic Bill Presentment and Payment Market: Report Forecast by 2032

[probablyasocialecologist]

The World Food Summit of 1996 approached food security through the principles of ensuring there is enough safe and nutritious food that can be accessed daily to meet healthy dietary needs and food preferences. By definition, this is a desirable and worthy goal. However, in the years since, food security has developed into a paradigm which does not question the underlying power dynamics and the reproduction of material conditions that make food insecurity a permanent feature of the global order. At its core, the food security paradigm deals only with access to food, without challenging the political and economic structures that determine and control access, as well as distribution.  By failing to address the root causes of hunger and famine, the food security paradigm makes it impossible to end hunger globally. Of course, many people worldwide possess food security, but this is restricted to increasingly limited geographic pockets. In terms of the people localised in one area, food vulnerability is influenced and determined by class, race, gender and, of course, citizenship status. Globally, “underdevelopment” and “de-development” lead to widespread food insecurity across areas. Another problem with the food security paradigm is that it is easily co-opted to generate partial answers that pose no threat to the corporate food system, or worse, that even open up new profit opportunities. Accelerated by other crises, the food security paradigm becomes ever more dependent on aid, be it through direct food delivery, cash transfers or small development projects that cannot compete with the food giants and their price-setting powers. In practice, a “science of food security” emerges, one which takes as its focus calories and the output that is compatible with precision agriculture having the aim to increase crop yields and to assist management decisions using high technology sensor and analysis tools. This model tends to be reliant on “Green Revolution” technologies that rely on chemical fertilisers and pesticides and that are tied to colonial projects and corporations, in order to optimise resources in aid response and/or development projects.  In this rationale, food insecurity can be addressed by reaching optimum yields of certain crops that should meet the demand for fats, fibres and protein. All of this is carefully managed and data-driven. Precision farming is advocated by the Alliance for a Green Revolution in Africa (AGRA) with the objective of optimising, “agricultural value chains […] critical in advancing food and nutrition sufficiency without increasing the size of land under cultivation.” The framing of food that reduces it only to “optimal input” relegates vital elements of food production and the culture of eating, like territory ownership, taste, heritage, care, well-being and connection as secondary. This reductionist approach has, though, proved useful to corporate agriculture, since it reinforces the case for genetically modified crops (GMOs), more efficient fertilisers, and the standardisation of food production for market purposes. Advocates of plant breeding technologies (including GMOs and hybrid seeds) argue that government overregulation is an obstacle to achieving food security. Overregulation, as the argument goes, denies populations the opportunity to grow crops that have increased nutrient use efficiency and are more resilient to climate shocks. 

[...]

The paradigm of food security is about optimising productivity. It’s true that productivity matters – after all, feeding the world requires enormous quantities of food. But if productivity is approached solely as a technological problem, it reinforces the tendency to fragment the quantitative and qualitative aspects of food production and consumption. On the quantitative side, production for food security is viewed as a challenge of multiplication. Whereas division, that is, distribution of food, is left to logistical planning. This ignores what Raj Patel identified in his influential 2007 book Stuffed and Starved, as the bottleneck of power that concentrates international food distribution among a small set of corporations. This bottleneck excludes the poor and small-scale food producers from decision-making. It also normalises worrying tendencies, such as an overreliance on industrial animal exploitation as a protein source, which has direct health implications, as well as longer term consequences like the proliferation of new viruses, greenhouse gas emissions and inefficient use of water and soil.

28 May 2024

[theblissfulstars]

New Moon in Aries March 21st, 11'23AM EST

The new moon happening on March 21st at 11:23 EST is definitely a doozy, and setting the stage for the final moments of the big transition before Pluto enters Aquarius and Mars enters Cancer.

This new moon is initiating the astrological new year as the sun is entering Aries. With the new moon occurring on the zodiac sign of Aries, there are definitely a lot of martian themes in this new moon. This is all about revolution, dynamism, explosivity and change taking place on a global scale. These are going to be changes largely regarding structures and hierarchies in patriarchy and other masculine dominated ideologies. This is the time of conflict, battle, and a new cycle of war being initiated. The MC for this new moon is in the zodiac sign of Aries, denoting a time of massive pivotal change, particularly regarding power dynamics that we've been wrestling with as a collective. This sun and moon are square transiting Mars in Gemini by degree orb denoting that this is going to be a time of dominance being asserted over the people collectively through information. Be very cognizant of the information that you were absorbing during this time as it is being utilized to control you and your energy, keep hope, keep faith and stay organized and mobile. Pluto is sextile the sun and moon, creating opportunities for transformations around power dynamics that assists the collective.

With Mercury at 5° in Aries, the number five numerologically resonates with change, motion and movement. With Mercury here who rules the number five, there are a lot of changes to our thoughts, thinking habits and modes of communication. There could be a major change in how we communicate from this new moon, for instance, new communication technologies being introduced or destroyed. With Chiron conjunct Jupiter and Vesta, there is a massive healing going on collectively surrounding ideologies and philosophies about masculinity, war and domination and how we're going to be healing that. Are we going to continue to allow this loop to continue or are we going to break it? With all of this happening in the 10th house, we can expect government, policy and hierarchical structures to play a major part in this new moon. Are we building a future we want or fear?

Venus in her dignity is at 5 degrees, conjunct Juno at 5. This here speaks to a fortuitous and wonderful time to find romantic, long-term love and romance. This is also an excellent time to look for business partnerships as well as consolidate and make things official in connections. There is a very heavy financial theme to this new moon, and the corporate space is going to be making major moves in how we handle our values, particularly around the environment, beauty and pleasure. This is a wonderful time for us to get our finances in check, and maybe even get some spiritual financial blessings. Venus is square Pluto, showing that the collective is going through a transformation of our values, particularly how power structures negatively affects our money and ability to have pleasure. The stock market is going through instability. Venus is sextile Saturn showing that there's an opportunity to stabilize if we use our minds and souls wisdom as a collective. With all of this taking place in the 11th house, get out there and socialize! This means it is going to be encouraging us to step outside of our houses. Make those connections, and at the risk of being crass, making those physical connections.

With Mars in the 12th, be aware of dreams this new moon and be safe in the astral. Don't let past trauma run the show, as unsublimated anxiety can break you down.

With a cancer ascendant capping this new moon with Pallas athene in cancer square Jupiter and Chiron in Aries, this speaks to a time of justice surrounding local politicians, figures of nationalism, and figures who are oppositional to feminine rights. We can expect issues around reproductive rights to arise.

Workings:

New beginnings

Money

Love

Seggs

Destruction

Revolution

Justice

[healthcarediagnosticmarket]

Progesterone Market Key Player Analysis: Growth Insights and Forecasts , Business Strategies, Challenges and Future Demand 2033

Global Progesterone Market Growth and Trends – Straits Research

Straits Research is pleased to present its comprehensive report on the global Progesterone Market, detailing market size, growth projections, trends, and key insights. With a projected CAGR of 12.3% from 2024 to 2032, the market is set to experience substantial growth, increasing from USD 1.50 billion in 2024 to USD 4.14 billion by 2032.

Market Definition:

Progesterone is a vital hormone, predominantly used in hormonal therapies. It plays a key role in regulating the menstrual cycle, supporting pregnancy, and managing conditions like dysfunctional uterine bleeding and endometrial cancer. There is a significant demand for progesterone in various medical treatments, driving its growing market share.

The global progesterone market is expected to grow rapidly due to increasing adoption of progesterone-based therapies for conditions such as menstrual irregularities, hormonal imbalances, contraception, and cancer therapies. This surge is also bolstered by the growing awareness of women's health and rising healthcare spending worldwide.

Market Size and Forecast

In 2023, the global progesterone market was valued at USD 1.34 billion. As the demand for progesterone-based treatments continues to rise, the market is projected to expand from USD 1.50 billion in 2024 to an estimated USD 4.14 billion by 2032. This growth will be driven by increasing healthcare expenditures, evolving consumer preferences for hormonal therapies, and expanding awareness around reproductive health.

Key Trends in the Progesterone Market:

Rise in Hormonal Therapy Awareness: The increasing awareness about the benefits of hormonal therapies, especially progesterone in regulating menstrual cycles and treating various gynecological disorders, is propelling the market's growth.

Technological Advancements in Drug Delivery Systems: Advances in the development of new drug delivery systems, such as injectable and oral progesterone formulations, are improving treatment outcomes and ensuring better patient compliance.

Growing Use in Contraceptive Treatments: The application of progesterone in contraception, particularly in the form of intrauterine devices (IUDs) and oral contraceptives, is significantly boosting market growth.

Growth Factors:

The progesterone market is witnessing substantial growth due to several driving factors:

Increasing Incidence of Hormonal Disorders: The rise in conditions like irregular menstrual cycles, menopause, and polycystic ovary syndrome (PCOS) is fueling the demand for progesterone-based treatments.

Expanding Healthcare Infrastructure in Emerging Economies: Improved access to healthcare, especially in regions like Asia-Pacific and Latin America, is driving the demand for progesterone therapies.

Aging Population and Increasing Healthcare Investments: With an aging global population and rising healthcare investments, the demand for progesterone, particularly in managing conditions related to reproductive health and endometrial cancer, is expected to rise.

Key Market Opportunities:

Unmet Needs in Fertility Treatments: There is a significant opportunity for the progesterone market to cater to the growing demand for fertility treatments, particularly in assisted reproductive technologies (ART) such as IVF.

Increasing Adoption of Bio-Similars: The adoption of bio-similar progesterone therapies, which offer cost-effective alternatives to branded treatments, presents significant growth opportunities for market players.

Research & Development in Personalized Medicine: Advancements in personalized medicine, tailored to specific hormonal needs, create opportunities for developing targeted progesterone therapies, thereby driving market expansion.

Market Segmentation:

The global progesterone market can be segmented as follows:

By Type:

<ol> <li>Natural Progesterone</li> <li>Synthetic Progesterone</li> </ol>

By Modes of Delivery Source:

<ol> <li>Injectable</li> <li>Suspended Form</li> <li>Oral</li> <li>Intravaginal</li> <li>Others</li> </ol>

By Application:

<ol> <li>Regulation of the Menstrual Cycle</li> <li>Dysfunctional Uterine Bleeding</li> <li>Endometrial Cancer</li> <li>Contraception</li> <li>Others</li> </ol>

For more detailed market segmentation, access the full report at this link.

Key Players in the Progesterone Market:

<ol> <li>Sofgen Pharmaceuticals</li> <li>Pfizer Inc.</li> <li>Cipla Limited</li> <li>Lupin</li> <li>Aquatic Remedies Pvt. Ltd.</li> <li>Wuhan Honor Bio-Pharm Co., Ltd</li> <li>Shanghai Yijing Industrial Co., Ltd.</li> <li>Estrellas Life Sciences Private Limited</li> <li>Intas Pharmaceuticals Ltd.</li> <li>AdvaCare Pharma</li> </ol>

Regional Insights:

Dominated Region: North America holds the largest share of the global progesterone market. The region's advanced healthcare infrastructure, higher demand for hormonal therapies, and extensive research and development activities have contributed to its dominance.

Fastest Growing Region: Europe is expected to be the fastest-growing market for progesterone due to an increasing awareness of reproductive health, an aging population, and the rising adoption of hormone-based treatments.

For More Information or Queries

To request more information, ask for customizations, or inquire about purchasing the full report, visit: this link.

Straits Research continues to provide insightful, data-driven research reports designed to help industry players, investors, and stakeholders make informed decisions. With our comprehensive analysis and projections, stakeholders can plan for future market developments and capitalize on emerging opportunities in the progesterone market.

About Straits Research:

Straits Research is a leading market research and consulting firm that provides in-depth analysis of global industries, delivering insights into market trends, forecasts, and strategic growth opportunities. With a robust team of experts and comprehensive data-driven reports, Straits Research helps clients gain a competitive edge and drive business growth.

Contact Us

Email: sales@straitsresearch.com

Address: 825 3rd Avenue, New York, NY, USA, 10022

Tel: UK: +44 203 695 0070, USA: +1 646 905 0080

[insightsresearch]

Male Infertility Market Manufacturers, Production, Consumption, Trade Statistics, and Growth Analysis

Analysis of Male Infertility Market Size by Research Nester Reveals the Market to Register a CAGR of 4.8% During 2025-2037 and Attain USD 8.4 billion by 2037

Research Nester assesses the growth and market size of the male infertility market which is anticipated to account for the growing demands for male fertility care as global awareness rises.

Research Nester’s recent market research analysis on “Male infertility Market: Global Demand Analysis & Opportunity Outlook 2037” delivers a detailed competitor’s analysis and overview of the global male infertility market in terms of market segmentation by category, financial institution, and end use.

Rising Demands for Premium Male Fertility Care to Cater to Rising Cases of Male Infertility Promote Global Market Growth

The growing cases of male infertility globally have led to greater investments in the research for male fertility care. Many nations are gripped with declining birth rates which makes addressing rising cases of male infertility of paramount importance. Governments across the globe are addressing the stigma associated with male infertility and spreading awareness to counter archaic notions. Certain countries, such as Japan, are integrating fertility care to public insurance to improve accessibility to general public. Additionally, early fertility care for men can drastically improve the chances of conceiving.

The market is expanding owing to rapid technological innovations in Assisted Reproduction Technologies (ART) which improves the efficacy of male fertility care. The integration of artificial intelligence (AI) to find male fertility care solutions is leading to a new dawn in male fertility care. As 5G services penetrate remote corners of the globe, the dissemination of information regarding the efficacy of male fertility care will be easier leading to a greater number of males actively seeking fertility solutions. As a testament to the growth of the market, in January 2023, Posterity Health, a digital male fertility center, raised USD 7.5 million led by early-stage venture capital fund Distributed Ventures.

Some of the major factors and challenges that are associated with global male infertility market are:

Growth Drivers:

Rising cases of lifestyle induced infertility rates in males

AI integration in assisted reproductive technologies

Challenges:

Male infertility care can be severely affected due to social stigmas associated with it. Fertility has long been associated with established tropes of masculinity which can impact male decisions in seeking fertility care. Despite multiple awareness drives, long-standing archaic beliefs are slow to dispel.

Access our detailed report at: https://www.researchnester.com/reports/male-infertility-market/6485

By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies & drug stores, online pharmacies, and others. The hospital pharmacies segment is estimated to have the highest revenue share during the forecast period. The growth of the segment is attributed to increasing footfalls in hospital pharmacies seeking male fertility care treatment. The rising cases of male infertility contribute to the robust growth of this segment.

By region, North America male infertility market is poised to generate the largest revenue share by the end of 2037. The growth of the regional market is attributed to rapid advancements in ART, the rising number of dedicated male fertility care clinics, and dedicated digital platforms where men can seek fertility care solutions. The region is pushing to dispel the stigma associated with male infertility care by offering digital platforms that are anonymous where men can seek solutions to their queries on fertility care. In February 2022, ExSeed Health that offers an app for male fertility care including solutions delivered to home, secured a USD 3.3 million funding to expand further in Europe.

Request Free Sample Copy of this Report @ https://www.researchnester.com/sample-request-6485

This report also provides the existing competitive scenario of some of the key players of the market i.e., Andrology Solutions, Merck, Vitrolife Group, Posterity Health, ExSeed Health, Bayer AG, Examen, and others.

Request for customization @ https://www.researchnester.com/customized-reports-6485

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives make wise decisions for their future marketing strategy, expansion investment, etc. We believe every business can expand to its new horizon, provided the right guidance at the right time is available through strategic minds. Our out-of-box thinking helps our clients to make wise decisions to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[memphasys]

We’re excited to share that our Felix™ System is nearing the completion of its clinical trial in Australia, with 95% of patient recruitment already completed. If current recruitment rates are maintained, the study is expected to conclude by the end of this calendar year. This will provide us with essential data to support our regulatory submissions and market expansion efforts. As demand for innovative fertility solutions continues to rise, Memphasys is positioning itself at the forefront of the global assisted reproductive technology (ART) market.

Read more : https://www.memphasys.com/memphasys-targets-global-fertility-market-as-clinical-trial-nears-completion/

[marketsndata]

Global In-Vitro Fertilization Market Size, Share, Growth and Forecast 2031

Global in-vitro fertilization market is projected to witness a CAGR of 7.52% during the forecast period 2024-2031, growing from USD 29.05 billion in 2023 to USD 51.89 billion in 2031. The market demand for in-vitro fertilization is anticipated to thrive drastically in the forecast years due to rising awareness and the growing interest of investors and market players.

In-vitro fertilization is one of the types of assisted reproductive technology and is the most common approach made in the care of patients with difficulty in conceiving. This is a procedure in which eggs are removed from a woman’s ovary and then combined with sperm outside the body to form embryos. The embryos are grown in the laboratory for a few days and then either placed in a woman’s uterus or cryopreserved (frozen) for future use, which is also called in-vitro fertilization. 

Infertility could be attributable to various lifestyle factors, including smoking, heavy alcohol consumption, and obesity. Infertility is a global health issue affecting millions of people of reproductive age worldwide. For instance, according to a report published by the World Health Organization (WHO) in April 2023, around 17.5% of the adult population – roughly 1 in 6 worldwide suffer from infertility problems. The new estimates indicate that limited regional difference exists in the prevalence of infertility. The rates were quite balanced among high-, middle- and low-income countries, making it a major burden for healthcare across the globe. The report further stated that the lifetime prevalence of infertility was at 17.8% among high-income countries, and among low- and middle-income countries, was at 16.5%. For instance, in May 2023, Artificial Intelligence In-vitro Fertilization (AIVF) Ltd., a developer of AI-based solutions for in-vitro fertilization clinics, and Genea Biomedx Pty Ltd., a global provider of medical devices for IVF laboratories, announced the launch of their integrated system. The new consolidated solution is aimed at providing safe personalized, optimized IVF care to a mass population.

Increased Prevalence of Infertility Rate to Support the Growth of IVF Market

Increased prevalence of infertility is one of the major factors which led to the growth of the market for in-vitro fertilization. Various socioeconomic factors, like late marriage and childbirth, and lifestyle factors, like bad diet, obesity, and stress, have led to higher rates of infertility across the world. Moreover, certain medical conditions, like polycystic ovary syndrome, endometriosis, and male infertility, are also becoming increasingly perceived, with these factors often complicating conception. Advanced medical technology, fertility options awareness, and the changing nature of social values toward assisted reproduction will only augment these increasing demands for in-vitro fertilization services. People and couples put more emphasis on planning for family-building and finding necessary fertility solutions. Thus, to cater to the increasing demand, fertility clinics are offering a wide portfolio of services and investing in various advanced technologies to ensure higher success rates, such as genetic screening and enhanced embryo culture techniques. This increased demand fuels growth for the IVF market. For instance, in August 2024, Fresenius SE & Co. KGaA’s U.S.-based subsidiary – Fresenius Kabi USA launched U.S. Food and Drug Administration (FDA) approved Cetrorelix Acetate injection kit. Cetrorelix Acetate injection is a prescription medicine for the hormonal treatment of ovarian stimulation.

Awareness and Advancements in Technology to Drive IVF Market Growth

Awareness and technological advances are vital drivers in the IVF market. The increase in public knowledge regarding infertility and the availability of treatment options has reflected greater acceptance of assisted reproductive technologies. Advances in technology, including better techniques for embryo culture, preimplantation genetic testing, and improvements in cryopreservation, have greatly increased the success rates of IVF treatment. This also makes the procedures more effective and can increase the number of options available to a patient, including genetic screening and the possibility of freezing eggs or embryos for future use. Fertility clinics increasingly embrace high-tech facilities to attract and retain patients and further foster market growth. With continued spreading awareness and technological advancements, the IVF market will expand steadily in the future. For instance, in December 2023, the U.S. FDA cleared the first over-the-counter artificial insemination kit manufactured by Mosie Inc. The approval of the artificial insemination kit is expected to drive the market by making fertility treatments more accessible, affordable, and inclusive.  

Culture Media Segment to Dominate the In-Vitro Fertilization Market

The culture media segment is forecast to dominate the market for in-vitro fertilization as it represents a crucial component in support of embryonic development and significant improvement of success rates. The culture media provides the minimum amount of nutrients and optimal conditions for embryos to be cultured outside the human body, making it an indispensable part of the IVF process. Advanced formulation techniques have ensured that these media work well and are tailored to different embryo development stages. However, the increasing impetus around personalized medicine and precision reproductive care requires demand for well-designed culture media for each patient that will ensure superior results. Accordingly, with increasing fertility treatments around the world and increasing cycles of IVF, the demand for high-quality culture media grows further.

Consequently, with unrelenting research and development, the growth in the culture media market is foreseen to be sturdy, which places it in a great position to fuel general growth in the IVF market. For instance, in July 2022, FUJIFILM Irvine Scientific, which develops and manufactures cell culture media and assisted reproductive technologies, announced the launch of its Heavy Oil for Embryo Culture, a sterile mineral oil that comes with optimal weight viscosity for the perfect balance of ease of use and protection.                                                                    

North America Dominates In-Vitro Fertilization Market

North America is leading the IVF market because of advanced medical technology, higher fertility treatment awareness, and strong healthcare infrastructure. It has a huge number of fertility clinics with specialized staff and well-equipped professionals. According to clinic-specific assisted reproductive technologies (ART) data released by the Society for Assisted Reproductive Technology (SART). In 2022, IVF babies increased by 2.5%, from 89,208 in 2021 to 91,771 in 2022. That represents 2.5% of all births in the U.S. and translates to successful ART cycles. Increased reports of cycle numbers point to the continued steady growth in demand for fertility services, even hostile legislation and threats of political interference. The total number of IVF cycles performed at the 368-member clinics of the Society for Assisted Reproductive Technology (SART) has grown by over 6% from 2021, from 368,502 in 2021 to 389,993 in 2022.

For instance, in February 2024, Femasys Inc., a biomedical company, received approval from the FDA for FemaSeed, a First-Line Infertility Treatment Option. Femasys is preparing for the commercial launch of FemaSeed in the U.S. There is a rise in the incidence of infertility due to late pregnancies and lifestyle factors and increased demand for assisted reproductive technology. Available treatment options, favorable policies, and certain insurance coverage contribute to more promising prospects for the growth of this market. Moreover, further research and development in applied reproductive technologies, including embryo culture techniques and genetic screening, keeps North America on top of the IVF industry. As societal attitudes toward fertility treatment increasingly change, such factors as the growing acceptance of fertility treatments show that North America will continue to dominate the market for IVF for the foreseeable future.

Download Free Sample Report

Future Market Scenario (2024-2031F)

The future market scenario of the in-vitro fertilization (IVF) market is poised for significant growth, driven by increased awareness of reproductive health, technological advancement, greater communication around reproductive health issues, and better social attitudes. With rising acceptance and a growing ability to access fertility treatments, many couples are looking toward IVF as a viable option for building families. The others include the improved success rate through technological advancement in embryo selection, advanced genetic screening, and even better culture media, therefore leading to tailoring treatment plans to improve further patient experiences, where focus is increasingly placed on personalized medicine. Another area that continues to expand is fertility preservation services, specifically egg and sperm freezing, which are adopted by younger demographics. For instance, in April 2023, Cryoport, Inc. signed a 3-year agreement with Boston IVF, LLC, a pioneer in reproductive healthcare and innovative research and one of the world’s most experienced fertility treatment providers.

Report Scope

“In-Vitro Fertilization Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global in vitro fertilization market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecasts between 2024 and 2031. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Click here for full report- https://www.marketsandata.com/industry-reports/in-vitro-fertilization-market

Latest reports-

Contact

Mr. Vivek Gupta 5741 Cleveland street, Suite 120, VA beach, VA, USA 23462 Tel: +1 (757) 343–3258 Email: info@marketsandata.com Website: https://www.marketsandata.com

[marketanalysisdata]

Biopreservation Market Revenue, Share and Growth Rate to 2030

The global biopreservation market was valued at USD 2.18 billion in 2022, and it is expected to grow at an impressive compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. This growth is driven by various factors, including extensive applications in healthcare settings like hospitals and laboratories, increased funding from both government and private entities, and advancements in research and development, particularly in the development of new products. For instance, BioLife Solutions introduced a new high-capacity controlled freezer in April 2021, aimed at supporting the cell and gene therapy sector. This addition helped the company expand its product range within biopreservation. The COVID-19 pandemic initially posed challenges for the industry, with disruptions in supply chains, shortages of raw materials, and slowdowns in research activities. However, it also accelerated interest and investment in biologics and vaccine technologies, which ultimately increased the demand for biopreservation solutions, especially for biologics manufacturing and preservation.

Biopreservation is a technique that enables the maintenance of biological materials such as stem cells, DNA, tissues, and organs under controlled temperatures, extending their viability outside their natural environment. Advances in technology, including microarrays, hybrid predictive models, and various API algorithms, are helping to streamline the biopreservation process by reducing its time, cost, and complexity. Additionally, the development of multiplex cellular imaging platforms is expected to boost biopreservation capabilities, especially in supporting disease research. These imaging platforms allow for better analysis of disease progression and facilitate targeted diagnostic and treatment strategies, benefiting fields like cardiology, gynecology, and point-of-care medicine.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Demand for biopreservation has significantly increased in the research and development of biologics across various sectors, including immunotherapy, vaccine production, antibody development, enzyme technology, and bio-manufacturing of chemicals. This surge is partially due to the rising global prevalence of chronic diseases. For example, according to the Centers for Disease Control and Prevention (CDC), cardiovascular diseases and cancer remain among the leading causes of mortality in adults in the United States.

In addition, government and private investments in research and development have spurred significant advancements in the market. There is growing demand for preserving stem cells and creating new biological treatments and products, which has attracted considerable attention and funding from investors. The substantial healthcare spending in this sector is likely to fuel the market's growth in the coming years.

However, the expanding biopreservation market faces some challenges. Key issues include a shortage of skilled professionals, high costs for training, and limited standardization in cybersecurity measures for biopreservation software. These factors may pose risks to market growth by adding complexity and increasing costs for companies operating in this space.

Application Segmentation Insights:

In terms of applications, the biobanking segment held a significant portion of the global market, accounting for 70.65% in 2022. The increasing awareness of stem cell preservation, rising acceptance of sperm and egg banking, and the use of assisted reproductive technologies in animals have all contributed to the segment’s growth. Many pharmaceutical companies are now collaborating with biobanks and hospitals for tissue and biological sample preservation.

The regenerative medicine segment is expected to grow at a higher CAGR of 29.68% during the forecast period, driven by a strong demand for advanced bio-storage techniques. Innovations in specific preservation techniques are likely to further boost growth in this segment over the coming years.

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[marketstudyreport]

Biopreservation Market Competitive Landscape and Industry Analysis 2030

The global biopreservation market was valued at USD 2.18 billion in 2022, and it is expected to grow at an impressive compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. This growth is driven by various factors, including extensive applications in healthcare settings like hospitals and laboratories, increased funding from both government and private entities, and advancements in research and development, particularly in the development of new products. For instance, BioLife Solutions introduced a new high-capacity controlled freezer in April 2021, aimed at supporting the cell and gene therapy sector. This addition helped the company expand its product range within biopreservation. The COVID-19 pandemic initially posed challenges for the industry, with disruptions in supply chains, shortages of raw materials, and slowdowns in research activities. However, it also accelerated interest and investment in biologics and vaccine technologies, which ultimately increased the demand for biopreservation solutions, especially for biologics manufacturing and preservation.

Biopreservation is a technique that enables the maintenance of biological materials such as stem cells, DNA, tissues, and organs under controlled temperatures, extending their viability outside their natural environment. Advances in technology, including microarrays, hybrid predictive models, and various API algorithms, are helping to streamline the biopreservation process by reducing its time, cost, and complexity. Additionally, the development of multiplex cellular imaging platforms is expected to boost biopreservation capabilities, especially in supporting disease research. These imaging platforms allow for better analysis of disease progression and facilitate targeted diagnostic and treatment strategies, benefiting fields like cardiology, gynecology, and point-of-care medicine.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Demand for biopreservation has significantly increased in the research and development of biologics across various sectors, including immunotherapy, vaccine production, antibody development, enzyme technology, and bio-manufacturing of chemicals. This surge is partially due to the rising global prevalence of chronic diseases. For example, according to the Centers for Disease Control and Prevention (CDC), cardiovascular diseases and cancer remain among the leading causes of mortality in adults in the United States.

In addition, government and private investments in research and development have spurred significant advancements in the market. There is growing demand for preserving stem cells and creating new biological treatments and products, which has attracted considerable attention and funding from investors. The substantial healthcare spending in this sector is likely to fuel the market's growth in the coming years.

However, the expanding biopreservation market faces some challenges. Key issues include a shortage of skilled professionals, high costs for training, and limited standardization in cybersecurity measures for biopreservation software. These factors may pose risks to market growth by adding complexity and increasing costs for companies operating in this space.

Application Segmentation Insights:

In terms of applications, the biobanking segment held a significant portion of the global market, accounting for 70.65% in 2022. The increasing awareness of stem cell preservation, rising acceptance of sperm and egg banking, and the use of assisted reproductive technologies in animals have all contributed to the segment’s growth. Many pharmaceutical companies are now collaborating with biobanks and hospitals for tissue and biological sample preservation.

The regenerative medicine segment is expected to grow at a higher CAGR of 29.68% during the forecast period, driven by a strong demand for advanced bio-storage techniques. Innovations in specific preservation techniques are likely to further boost growth in this segment over the coming years.

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[healthcaremarketanalysis]

Urology Devices Market: Trends, Growth, and Innovations Shaping the Future

The urology devices market is expanding rapidly, driven by rising cases of urological diseases, a growing elderly population, and significant advancements in medical technology. Urology is a specialized field focused on diagnosing, treating, and managing conditions related to the urinary tract and male reproductive organs, including the kidneys, bladder, ureters, and prostate. Urology devices play a vital role in supporting urologists in delivering effective treatments and improving patient outcomes. This blog provides an in-depth look at the current trends, growth factors, and key innovations in the urology devices market.

Download PDF Brochure

Market Overview and Key Drivers

The global urology devices market has been steadily growing and is projected to continue on this path, with recent estimates suggesting a CAGR of over 6% from 2023 to 2030. Some of the major drivers behind this growth include:

Rising Prevalence of Urological Disorders

Urological diseases like kidney stones, urinary incontinence, and prostate cancer are increasingly common, particularly in older adults. With a significant portion of the population now aging, demand for effective urological care and advanced diagnostic devices is on the rise. Additionally, lifestyle factors such as sedentary habits and diet can contribute to issues like kidney stones and urinary infections, further fueling the market for urology devices.

Technological Advancements

Innovations in technology have led to the development of minimally invasive surgical instruments, advanced imaging systems, and improved diagnostic devices, all of which enhance precision and reduce patient recovery time. Technologies such as robotics, laser-assisted devices, and minimally invasive techniques are becoming standard in urological procedures, enabling less invasive options for treatment and fewer complications.

Increase in Chronic Kidney Diseases and Cancers

Rising rates of chronic kidney disease and prostate cancer worldwide are significantly impacting the demand for urology devices. Prostate cancer is the second-most common cancer among men globally, leading to increased use of diagnostic imaging, biopsy devices, and treatment instruments.

Growing Awareness and Healthcare Spending

Increased public awareness of urological conditions, combined with rising healthcare expenditures, has encouraged patients to seek timely treatment, boosting demand for innovative devices.

Key Segments in the Urology Devices Market

The urology devices market can be categorized into several key segments, including diagnostic devices, treatment devices, and consumables.

1. Diagnostic Devices

Diagnostic devices in urology are essential for accurately identifying urological diseases. Common devices include:

Ultrasound Systems: Used to create images of the kidneys, bladder, and prostate. Portable ultrasound devices are increasingly popular due to their convenience and cost-effectiveness.

Endoscopes: Instruments that allow visualization of the urinary tract, including cystoscopes, ureteroscopes, and nephroscopes.

Biopsy Devices: Used to collect tissue samples from the prostate or bladder for cancer diagnosis.

2. Treatment Devices

Urological treatment devices aim to either alleviate symptoms or eliminate disease. Key devices include:

Lithotripters: Used in treating kidney stones by breaking them down using shock waves. There are different types of lithotripters, including extracorporeal shock wave lithotripsy (ESWL) and laser lithotripsy, both widely used in non-invasive treatments.

Catheters and Stents: Essential for managing urinary retention and supporting urinary flow, particularly after surgery.

Dialysis Equipment: For patients with chronic kidney failure, dialysis machines offer life-saving treatment.

Robotic Surgical Systems: Robotic systems like the da Vinci Surgical System have transformed prostate surgeries and other urological procedures by enabling precision and minimally invasive techniques.

Prostate Treatment Devices: These include devices used in transurethral resection of the prostate (TURP), prostate ablation, and laser therapy.

Request Sample Pages

3. Consumables and Accessories

Consumables such as urological catheters, guidewires, and biopsy needles are essential tools in both diagnostic and treatment procedures. As these products are single-use, they represent a consistent revenue stream within the market.

Technological Innovations and Emerging Trends

Several exciting innovations are currently reshaping the urology devices market. These advancements not only improve diagnostic and treatment capabilities but also enhance patient safety and comfort.

Robotic-Assisted Surgery

Robotic technology in urology has significantly improved precision in procedures like prostatectomies and kidney surgeries. Robotic-assisted systems allow surgeons to perform complex procedures with greater accuracy and reduced blood loss, leading to faster patient recovery times. The rising popularity of robotic surgery has led to substantial investments in this field, with new models and systems regularly entering the market.

Artificial Intelligence (AI) and Machine Learning (ML)

AI-powered imaging systems and diagnostic tools are helping urologists detect diseases more accurately and at earlier stages. Machine learning algorithms can analyze vast amounts of data to predict disease patterns, patient outcomes, and personalized treatment options, potentially revolutionizing urological care.

Laser Technology

Laser lithotripsy is a widely used method for treating kidney stones. Laser technology has become more sophisticated, enabling procedures that are highly effective in breaking down stones and improving patient outcomes with minimal side effects.

Minimally Invasive and Non-Invasive Techniques

The demand for non-invasive urological treatments has led to significant improvements in devices that enable procedures without the need for large incisions. Techniques such as laser therapy, shock wave lithotripsy, and cryotherapy are increasingly favored by patients and physicians alike due to shorter recovery times and reduced risk of complications.

Wearable and Remote Monitoring Devices

New wearable devices for monitoring urinary functions and detecting infections in real time are being developed. These tools are particularly valuable for elderly patients and those with chronic conditions who require regular monitoring. Remote monitoring allows for real-time data collection and helps in managing conditions like urinary incontinence and kidney diseases outside of hospital settings.

Regional Market Insights

The urology devices market is experiencing significant growth in several regions worldwide:

North America: The largest market, driven by high healthcare spending, an aging population, and technological advancements. The U.S. is a major contributor, with substantial investments in healthcare infrastructure and research.

Europe: Europe’s market is also strong, supported by high awareness of urological diseases and government healthcare programs.

Asia-Pacific: This region is expected to witness the highest growth rate due to the increasing prevalence of urological diseases, a large patient base, and rising healthcare expenditures in countries like China, India, and Japan.

Challenges and Future Prospects

While the urology devices market is growing, it faces some challenges:

High Costs of Advanced Devices

Advanced urology devices, such as robotic systems and AI-integrated imaging tools, are often costly, which can limit their accessibility, especially in developing countries.

Regulatory Hurdles

Urology devices undergo rigorous testing and regulatory approvals, which can delay the launch of new products. Changes in regulatory policies across regions also add to the complexity and cost for manufacturers.

Shortage of Skilled Professionals

Some urology devices, particularly robotic and laser systems, require skilled practitioners. A shortage of trained personnel in emerging markets can hinder the adoption of these advanced devices.

Despite these challenges, the future of the urology devices market appears promising. Increasing investments in research, favorable regulatory policies in many countries, and a focus on enhancing patient care are likely to sustain growth in this sector.

Inquire Before Buying

Conclusion

The urology devices market is set to play a crucial role in the healthcare industry, meeting the rising demand for effective and minimally invasive solutions for urological conditions. From robotic surgery systems to AI-powered diagnostics, innovation is at the heart of this growth, helping to improve outcomes for patients with conditions affecting the urinary tract and reproductive organs. As advancements continue, the urology devices market will likely offer more accessible, affordable, and efficient solutions, shaping the future of urological care on a global scale.

[medlineacademics]

Specialists in Reproductive Medicine and IVF in India - Emerging Market Demand

Introduction

With IVF being the most sought for technique in ART realms, India is now seen as one of the premier places to head for treatment. Such a heightened popularity of nontraditional types of childless treatment can be explained by the growing role of unhealthy lifestyles and thus, the need for professional IVF surgeons has never been higher. This demand is therefore exerting a pull for more specific training especially fellowship for potential medical practitioners to acquire more of these expert skills.

Why Specialized Training is Crucial in Reproductive Medicine?

Reproductive medicine itself is a very specialized branch of infertility treatment and has expanded rapidly with ongoing research and development in the last few years. A Fellowship in Reproductive Medicine certifies the healthcare professional on aspects of ART methods and embryology and the management techniques needed to provide top-notch IVF services. This is important because chances of conceiving through IVF largely depend on the doctors involved in the procedure.

Exploding popularity in medical tourism, coupled with top-notch IVF facilities, makes India the right place for IVF fellowship. Indian hospitals offer some of the best training and infrastructure assistance especially the multi-specialty hospitals in Bangalore ensure the IVF specialist gets enormous opportunity to have global exposure and clinical edge to rival the foremost standards of IVF procedure.

Fellowship in IVF and Reproductive Medicine: Turning your dream into a successful profession

A Fellowship in Reproductive Medicine is a more advanced program compared with basic training, which includes dedicated modules on embryology and andrology, clinical IVF management and ovarian stimulation protocols and patient management and counselling. Such programmes are useful since they are able to equip the candidates with every aspect of Reproductive Health hence are well equipped to handle most instances.

Some highlights of a Fellowship in IVF in India include:

- Hands-on Training in IVF Labs: Fellows are able to perform related laboratory processes, such as ICSI, embryo freezing and retrieving eggs.

- Simulation Training: This is achieved through numerous programs that enhance the skills by use of simulations in order to get fellows as close as possible to real life experience.

- Mentorship from Leading Experts: Students follow masters’ advice which is extremely important when it comes to clinical skill development and diagnostics.

- Cutting-edge Technology: The trainings for the fellows unveil the recent research on medical technology, which is available in the center.

Once doctors finish their fellowship in reproductive medicine, they are ready to practice as reproductive medicine specialists in IVF hospitals particularly in ‘THE’ Bangalore. This training leads to employment in private sectors IVF clinics, research occupations, teaching and even administrative and managerial positions in the specialty.

Why Bangalore is Suitable for IVF Training as well as Treatment

Indeed, Bangalore is one of the leading centres globally for fertility tourism and training and development of fertility specialists. This city reputed for high standards of medical services contains some of the best IVF hospitals in India and can, therefore, accommodate medicine fellows in reproductive health.

Some of the Best IVF Hospital in Bangalore

The IVF hospitals in Bangalore have good infrastructure, equipment and personnel who have trained from different parts of the world. Different network hospitals here offer all types of ART treatment like IVF, ICSI and egg freezing with close embryologist assistance and counselling service. The nature of training provided by IVF hospitals in Bangalore is that the fellows get to practice in multiple fields due to the huge workload.

List of Renowned Institutes for Fellowship Programs In Bangalore

There are several well-known institutes in Bangalore that provide fellowship in IVF and reproductive medicine with emphasis on academic, ethical and practical aspects thereof. Not only do these institutions equip the fellows with skills as to how to tackle clinical issues but also with confidence as to how to approach the patients and make a clinical decision.

Patient-Centric Training

Professional and personal fellowship programmes in Bangalore especially focus on patient-centred care education where fellows are trained to address the patients since they are key players in their treatment, counselling, and mental health, this goes hand in hand with IVF.

The special programs weave the future of reproductive medicine through consolidated training.

For those willing to work under state of art embryology lab and microscope a fellowship in IVF is not merely a journey towards a potentially rewarding career but it is a promise to contribute towards the field of reproductive medicine. Given the fact that this training endows doctors with comprehensive knowledge and effective skills, this training will doubtless influence the quality of IVF treatment offered to patients and subsequently increase success rate and satisfaction among patients.

Why Reproductive Medicine Fellowship in Bangalore Facilities?

A plethora of specialized IVF hospitals and a rich environment for the development of reproductive medicine makes Bangalore the ideal place for young specialists. The commitment of the city to offer quality training with state-of-the-art technology and liaising with experts in the medical field offers a perfect environment for dedicated doctors who desire to be part of change in the fertility and reproductive medicine.

IIRRH

The International Institute for Training and Research in Reproductive Health (IIRRH) is a prime institute for training in reproductive medicine. Dr Kamini Rao established IIRRH, which to date, is among the only few institutes offering complete fellowships and certification in ART and reproductive healthcare.

Key Offerings

- Fellowship Programs in Reproductive Medicine: Exciting specialized fellowships at IIRRH for candidates who wish to make their career in reproductive medicine involving detailed theoretical and practical knowledge of ART.

- Certification Courses: The following are short term certification courses offered by IIRRH most of which are designed for healthcare practitioners interested in acquiring specific knowledge in the areas of embryology, IVF, andrology and reproductive endocrinology.

- Research Opportunities: IIRRH is well-endowed with a robust research capacity, which the institute urges fellows and clinicians to come up with innovative research and enhance the body of knowledge on reproductive health.

Mission and Vision

The mission of IIRRH is to act as the mecca for standards of reproductive medicine education and research. It is therefore the vision of IIRRH to cultivate professional human resource that produce ethical and competent ART services to the world.

Medline Academics

Medline Academics is uniquely dedicated to providing superior, hands-on, and effective education in reproductive medicine, infertility and IVF to educational establishments. Through the support of Dr. Kamini Rao, Medline Academics provides the gap in knowledge to make doctors have access to premier online and offline training programs making it ideal to doctors in reproductive medicine in turn making it an institution of choice when it comes to flexible learning.

Key Offerings

- Online Fellowship in Reproductive Medicine: This online fellowship program is created for doctors who want to focus on the reproduction field and offers them the curriculum with the modules, cases, and tests.

- Simulation-Based Training: Medline Academics has been training students through simulation laboratory; this enhances students’ practical skills as they prepare for practice settings.

- Specialized Courses in IVF and ART: These includes basic IVF treatment protocols, and other aspects of ART means Medline Academics a one stop shop for learning all things reproductive health.

Mission and Vision

Medline Academics aims at providing affordable high-quality education in the field of reproductive medicine for all professionals globally. Its goals include the development of the future specialists in the sphere of reproductive health, who would be equipped with the necessary knowledge, moral and ethical values, essentials for the competent imparting of ideas and notions to their patients, while communicating with them.

Dr. Kamini Rao Hospitals

Dr. Kamini Rao Hospitals is a leading fertility, and reproductive health care center in Bangalore. These hospitals are initiated by Dr. Kamini Rao who is the leading and renowned infertility specialists in India and these hospitals have created and achieved standards of service delivery that includes high quality Fertility care along with ART services to the couple who in turn have received humane and empathetic treatment during their infertility management.

Key Services

- Comprehensive IVF and Fertility Treatments: The hospital boasts of providing all aspects of ART services from In Vitro Fertilization, Intracytoplasmic Sperm Injection, Intrauterine insemination and even egg preservation to suit individual clients.

- Patient-Centric Approach: Dr. Kamini Rao Hospitals have incorporated a concept of patient psychology and emotions and support the patients from all aspects of their treatment process.

- Training and Mentorship: The hospital also acts as a training ground for fellow and residents in IIRRH and Medline Academics as they get exposure to varieties of cases.

Mission and Vision

Dr Kamini Rao Hospitals want to be a leading healthcare organization for child bearing age people offering reproductive health solutions based on commitment, quality and ethics. Encouraging constant development, the hospitals try to raise the probability of ART and provide accessible infertility treatments for people.

Final Thoughts

Doing Fellowship in Reproductive Medicine in Bangalore is a life changing experience which empowers the doctors with knowledge, confidence and compassion to spearhead the IVF treatment. As India progresses further in this particular field of reproductive medicine the future generations of doctors will be better equipped to handle such cases to the benefits of their clients.

[industrynewsupdates]

Key Drivers Shaping the Preimplantation Genetic Testing Market

The global preimplantation genetic testing market was estimated to be valued at USD 802.2 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2030. The increasing prevalence of single-gene, mitochondrial, and other genetic disorders is expected to drive the demand for preimplantation diagnosis and screening processes in the coming years. According to the Florida Department of Health, approximately one in every 33 babies born in the U.S. is affected by a congenital disability, which translates to nearly 120,000 affected infants each year. With the introduction of new testing options, demand for preimplantation genetic testing is anticipated to rise. For example, in July 2023, Thermo Fisher Scientific Inc. launched two tests based on next-generation sequencing (NGS) specifically for preimplantation genetic testing for aneuploidy (PGT-A).

Preimplantation genetic diagnosis (PGD) is a procedure utilized prior to in vitro fertilization (IVF) to enhance the chances of a successful pregnancy. PGD is commonly used in IVF cycles for women who have faced multiple miscarriages or have had previous pregnancies involving chromosomal abnormalities. This method is particularly advantageous for couples at risk of hereditary disorders, contributing positively to market growth.

The incorporation of aneuploidy screening within PGD has notably improved the outcomes of IVF procedures. Aneuploidy testing in IVF clinics enables the identification of abnormal embryos, which in turn leads to higher success rates for pregnancies. Preimplantation genetic testing for aneuploidy (PGT-A) assesses embryos for chromosomal abnormalities, ensuring that the correct number of chromosomes is present. The benefits of PGT-A, such as increased likelihood of pregnancy, lower miscarriage rates, and fewer IVF cycles required to achieve a successful pregnancy, are expected to further enhance the adoption of these tests throughout the forecast period.

Gather more insights about the market drivers, restrains and growth of the Preimplantation Genetic Testing Market

Drivers, Opportunities & Restraints

The increasing incidence of genetic diseases has significantly boosted the demand for preimplantation genetic testing (PGT). As the prevalence of genetic disorders rises, PGT has become essential in in vitro fertilization (IVF) procedures. This type of testing plays a crucial role in identifying and preventing the transfer of genetic abnormalities, thereby enhancing the likelihood of successful pregnancies. Innovations such as preimplantation genetic testing for aneuploidy (PGT-A) and monogenic diseases (PGT-M) have further improved clinical outcomes, leading to reduced miscarriage rates and a lower risk of hereditary conditions. As a result, the adoption of PGT is expected to grow, driven by its effectiveness in detecting and managing genetic disorders.

Additionally, the rising rate of infertility has significantly contributed to the increasing demand for PGT in assisted reproductive technologies (ART). Infertility affects millions of individuals worldwide, with contributing factors such as delayed childbearing, lifestyle changes, environmental influences, and underlying health conditions playing critical roles. As more couples seek solutions for infertility, in vitro fertilization has become a prominent method for achieving pregnancy. Within the IVF framework, PGT is vital, ensuring the selection of genetically healthy embryos for implantation, which in turn enhances the chances of a successful pregnancy.

Preimplantation genetic testing, encompassing both PGT-A and PGT-M, assists in identifying chromosomal abnormalities and specific genetic disorders in embryos prior to implantation. This capability not only increases the likelihood of achieving a successful pregnancy but also minimizes the risks of miscarriage and genetic disorders in future offspring. The ability of PGT to screen for genetic issues before pregnancy provides reassurance to couples facing infertility, offering better outcomes and reducing the number of cycles required to achieve pregnancy. Furthermore, advancements in testing technologies have significantly improved the accuracy and reliability of PGT, which is driving its increased adoption. As infertility rates continue to climb, the utilization of PGT within ART is expected to expand, providing hope and viable solutions for those struggling with infertility.

Order a free sample PDF of the Preimplantation Genetic Testing Market Intelligence Study, published by Grand View Research.